CAS 786593-06-4: (2R,5R,6S,10R)-2,17-bis[(3-carboxypropanoyl)oxy]-20-oxo-9,19-didehydro-5,6,7,8,9,10,15-octahydro-20:5,10-dicycloretinal

Dehydroandrographolide Succinate is a traditional Chinese medicine used in the treatment of pneumonia, respiratory tract infection.

Dehydroandrographolide succinate is a pharmacological agent derived from the diterpenoid lactone, andrographolide, which is found in the plant *Andrographis paniculata*. This compound exhibits its mode of action primarily by modulating inflammatory pathways, including inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and the reduction of pro-inflammatory cytokines. These actions contribute to its anti-inflammatory and immunomodulatory properties. Dehydroandrographolide succinate is employed in the treatment of various conditions characterized by inflammation and immune dysregulation. This includes its use in managing upper respiratory tract infections and its potential therapeutic applications in autoimmune diseases. Additionally, its role is being explored in the modulation of specific signaling pathways relevant to cancer and other chronic inflammatory conditions, making it a subject of research for targeted therapies. The compound's efficacy, safety profile, and mechanisms continue to be areas of active investigation within pharmacological and biomedical research.

4-(((1R,2R,4Ar,5R,8As)-2-((3-Carboxypropanoyl)Oxy)-1,4A-Dimethyl-6-Methylene-5-((E)-2-(2-Oxo-2,5-Dihydrofuran-3-Yl)Vinyl)Decahydronaphthalen-1-Yl)Methoxy)-4-Oxobutanoic Acid

Dehydroandrographolide succinate